Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 6.79B 1.02B 906M 839M 763M 1.43B 96.61B 1.46B 10.07B 3.95B 50.37B 3.82B 3.74B 161B P/E 2026 *
67.1x
P/E 2027 * 51.3x
Enterprise Value 6.79B 1.02B 906M 839M 763M 1.43B 96.61B 1.46B 10.07B 3.95B 50.37B 3.82B 3.74B 161B EV / Sales 2026 *
6.23x
EV / Sales 2027 * 5.48x
Free-Float
62.75%
Yield 2026 *
-
Yield 2027 * -
09-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd.(XSEC:301188) added to S&P Global BMI Index CI
08-24 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
04-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
04-06 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
03-31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
12-15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
12-14 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
11-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
27/10/25 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
09/10/25 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
1 day-1.39%
1 week-11.59%
Current month-21.36%
1 month-23.61%
3 months-31.17%
6 months+4.43%
Current year+48.69%
1 week 24.95
Extreme 24.95
29.2
1 month 24.95
Extreme 24.95
38.86
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 14/04/2024
Director of Finance/CFO 45 28/11/2022
Investor Relations Contact - -
Director TitleAgeSince
Chairman 51 30/10/2025
Chairman 47 31/12/2023
Director/Board Member 54 05/04/2015
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%-11.59%+55.31%+115.04% 1.03B
+0.23%+5.35%+7.85%+1.50% 20.26B
+0.89%+5.12%-17.25%+40.96% 18.63B
+1.01%+9.20%+32.09%+41.36% 16.73B
+0.14%+4.61%+10.11%-2.04% 13.29B
+0.65%+6.12%+22.43%+41.49% 12.27B
-0.36%+2.55%+25.30%+75.33% 11.73B
-0.84%+2.59%+14.86%-13.87% 8.96B
+0.10%+3.53%-3.64%-1.70% 7.92B
0.00%-12.61%+67.50%+649.40% 5.88B
Average +0.04%+2.81%+21.46%+94.75% 11.67B
Weighted average by Cap. +0.30%+4.51%+14.05%+57.01%

Financials

2026 *2027 *
Net sales 1.09B 163M 145M 135M 123M 230M 15.51B 234M 1.62B 635M 8.09B 613M 600M 25.9B 1.24B 186M 165M 153M 139M 261M 17.62B 266M 1.84B 721M 9.18B 696M 682M 29.41B
Net income 103M 15.44M 13.74M 12.73M 11.58M 21.74M 1.47B 22.12M 153M 59.98M 764M 57.94M 56.7M 2.45B 137M 20.54M 18.28M 16.93M 15.4M 28.92M 1.95B 29.43M 203M 79.77M 1.02B 77.06M 75.42M 3.25B
Net Debt - -
Projected Income Statement - Annual - Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
19/10/26 CN¥26.17 -1.39% 6,717,400
16/10/26 CN¥26.54 +0.34% 8,553,403
15/10/26 CN¥26.45 -4.92% 7,335,293
14/10/26 CN¥27.82 -3.34% 6,689,685
13/10/26 CN¥28.78 +0.07% 9,198,890

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Shandong Linuo Pharmaceutical Packaging Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 301188 Stock